Principal Financial Group
ROIV icon

Principal Financial Group’s Roivant Sciences ROIV Stock Holding History

Principal Financial Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.2M Buy
1,024,140
+18,607
+2% +$550K 0.02% 654
2026
Q1 		$27.9M Buy
1,005,533
+64,311
+7% +$1.65M 0.01% 727
2025
Q4 		$20.4M Sell
941,222
-12,711
-1% -$251K 0.01% 889
2025
Q3 		$14.4M Sell
953,933
-18,402
-2% -$228K 0.01% 1054
2025
Q2 		$11M Buy
972,335
+3,696
+0.4% +$40.1K 0.01% 1209
2025
Q1 		$9.77M Sell
968,639
-15,880
-2% -$172K 0.01% 1272
2024
Q4 		$11.6M Sell
984,519
-25,239
-2% -$298K 0.01% 1211
2024
Q3 		$11.7M Sell
1,009,758
-145,614
-13% -$1.66M 0.01% 1178
2024
Q2 		$12.2M Sell
1,155,372
-119,365
-9% -$1.31M 0.01% 1150
2024
Q1 		$13.4M Buy
1,274,737
+1,238,460
+3,414% +$13.4M 0.01% 1155
2023
Q4 		$407K Sell
36,277
-5,428
-13% -$52.9K ﹤0.01% 1998
2023
Q3 		$487K Buy
41,705
+13,106
+46% +$148K ﹤0.01% 1959
2023
Q2 		$288K Buy
+28,599
New +$256K ﹤0.01% 2088

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Principal Financial Group's ROIV Position: Q2 2026 in Review

Principal Financial Group increased its Roivant Sciences (ROIV) stake by 1.9% in Q2 2026, buying an estimated $550K and bringing the position to 1,024,140 shares worth $36.2M. The position accounts for 0.02% of the portfolio, ranked #654.

Principal Financial Group first reported a position in ROIV in Q2 2023 and has held it in 13 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Principal Financial Group held 1,024,140 shares of Roivant Sciences worth $36.2M as of Q2 2026.
  • Principal Financial Group bought 18,607 Roivant Sciences shares in Q2 2026, an estimated $550K.
  • Roivant Sciences made up 0.02% of Principal Financial Group's portfolio in Q2 2026, its #654 holding.
  • Principal Financial Group first reported a position in Roivant Sciences in Q2 2023 and has held it in 13 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.